<DOC>
	<DOCNO>NCT00751452</DOCNO>
	<brief_summary>determine interest dosage citrullinemia monitor bowel damage allogeneic bone marrow transplantation child .</brief_summary>
	<brief_title>Citrulline Allo . Evaluation Citrullinemia Marker Bowel Damage After Allogeneic Bone Marrow Transplantation Children</brief_title>
	<detailed_description>30 child include . Dosage citrullinemia day -7 , day 0 every week 100 day BMT . Histological examination extensive infectious screen case persistent digestive symptom ( 3 day ) . Two group patient regard digestive involvement . Comparison value citrullinemia two group .</detailed_description>
	<mesh_term>Citrullinemia</mesh_term>
	<criteria>0 18 year allogeneic bone marrow transplantation malignant benign disease affiliation French sécurité sociale parent 's consent severe gastrointestinal involvement transplant previous digestive surgery</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>18 Years</maximum_age>
	<verification_date>January 2011</verification_date>
	<keyword>Children</keyword>
	<keyword>Allogeneic bone marrow transplantation</keyword>
	<keyword>Intestinal damage</keyword>
	<keyword>Citrulline</keyword>
	<keyword>Graft versus Host Disease</keyword>
	<keyword>0 18 year old</keyword>
</DOC>